Advanced Nano-Based Drug Delivery Systems for Infectious Diseases
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 1013
Special Issue Editors
Interests: drug delivery; nanotechnology; nanomedicines; neglected diseases
Special Issue Information
Dear Colleagues,
Infectious diseases, caused by different microorganisms, are still a leading cause of morbidity and mortality worldwide. From common bacterial infections to more complex parasitic and fungal diseases, the global burden is immense, resulting in millions of deaths every year. Despite the availability of a range of therapeutic tools, these infections often evade treatment due to limited drug options, resistance development, and severe side effects associated with current therapies.
The urgent need for novel and more effective treatment strategies has spurred significant research into nanomedicines—a promising frontier in infectious disease management. Nanomedicines, leveraging the unique properties of nanoparticles, are revolutionizing the way we approach infection treatment. These advanced therapeutic agents have the potential to overcome many of the limitations posed by traditional drugs. By enhancing the bioavailability, specificity, and targeted delivery of drugs, nanomedicines can increase treatment efficacy while minimizing toxicity and side effects.
This Special Issue aims to highlight recent advancements in nanomedicines for combating infectious diseases. It invites original research and review articles that focus on the following:
- Innovative Strategies: Addressing the challenges associated with widespread microbial infections.
- New Therapeutic Approaches: The development of novel treatments for infection control, including new drug formulations and therapeutic targets.
- Mechanisms of Action: Detailed studies of how nanomedicines interact with microbial agents at a molecular level.
- Novel Diagnostic Systems: The design of advanced diagnostic tools for more accurate detection of infections.
- Enhanced Drug Delivery: Strategies for improving the efficacy of treatments, including new delivery systems, combined therapies, and targeted approaches.
- Improved Tolerability: New formulations to enhance patient comfort and minimize side effects.
This Special Issue aims to bring together cutting-edge research and innovative strategies related to the use of nanomedicines in infectious disease management. We encourage submissions that explore new therapeutic approaches, novel drug delivery systems, and the latest advancements in the understanding of how nanomedicines can combat microbial infections. With continued research and development, nanomedicines have the potential to revolutionize the way we treat infections, offering new hope for millions of patients worldwide.
Prof. Dr. Claudio J. Salomon
Prof. Dr. Maria Celina Lamas
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomedicines
- infectious disease
- microorganisms
- therapeutic treatments
- drug delivery systems
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
